ZFP36L2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.24990000016645E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.87640000004485E-06 |
Normal-vs-Stage2 |
7.59390000000248E-05 |
Normal-vs-Stage3 |
6.5760000000914E-08 |
Normal-vs-Stage4 |
2.20480000923118E-09 |
Stage1-vs-Stage2 |
6.590600E-01 |
Stage1-vs-Stage3 |
5.016100E-02 |
Stage1-vs-Stage4 |
1.242700E-03 |
Stage2-vs-Stage3 |
4.333800E-01 |
Stage2-vs-Stage4 |
1.461430E-01 |
Stage3-vs-Stage4 |
3.419000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.38269999683649E-08 |
Normal-vs-AfricanAmerican |
2.981500E-03 |
Normal-vs-Asian |
1.497970E-01 |
Caucasian-vs-AfricanAmerican |
6.052400E-02 |
Caucasian-vs-Asian |
4.267800E-01 |
AfricanAmerican-vs-Asian |
9.173400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.31179999879927E-08 |
Normal-vs-Female |
1.02140000002304E-06 |
Male-vs-Female |
2.834400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.93639999999507E-05 |
Normal-vs-Age(41-60Yrs) |
5.61759999961886E-07 |
Normal-vs-Age(61-80Yrs) |
1.56170000042977E-07 |
Normal-vs-Age(81-100Yrs) |
9.15750000052284E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.293000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.201000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.595400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.521000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.893230E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.755600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.063480E-03 |
Normal-vs-Grade 2 |
2.312399999993E-05 |
Normal-vs-Grade 3 |
1.82620000233058E-08 |
Normal-vs-Grade 4 |
3.94679999793368E-09 |
Grade 1-vs-Grade 2 |
7.451200E-01 |
Grade 1-vs-Grade 3 |
1.549560E-01 |
Grade 1-vs-Grade 4 |
4.280400E-02 |
Grade 2-vs-Grade 3 |
3.804200E-03 |
Grade 2-vs-Grade 4 |
8.778100E-04 |
Grade 3-vs-Grade 4 |
3.048800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.68370000006324E-07 |
Normal-vs-ccB subtype |
1.51169999962342E-07 |
ccA subtype-vs-ccB subtype |
3.768200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.75259999957156E-07 |
Normal-vs-N1 |
3.644000E-04 |
N0-vs-N1 |
7.748000E-01 |
|
|